<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02455661</url>
  </required_header>
  <id_info>
    <org_study_id>2014-560N-MA</org_study_id>
    <nct_id>NCT02455661</nct_id>
  </id_info>
  <brief_title>Femoral Closure Versus Radial Compression Devices Related to Percutaneous Coronary Interventions Study</brief_title>
  <acronym>FERARI</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsmedizin Mannheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      FERARI is a single centre observational study comparing patients undergoing PCI either using
      radial compression devices or femoral closure devices at the corresponding access site.

      First primary outcomes consist of the occurrence of vascular complications at the arterial
      access site including major bleedings as defined by common classification systems

      Second primary outcomes consist of the occurrence of adverse cardiac events including
      all-cause mortality, target lesion and vessel revascularization (TLR and TVR) during 30 days
      and 12 months of follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2014</start_date>
  <completion_date type="Actual">October 2019</completion_date>
  <primary_completion_date type="Actual">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Radial closure by TR-Band.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vascular complications at the arterial access site</measure>
    <time_frame>30 days</time_frame>
    <description>Occurrence of vascular complications at the arterial access site including major bleedings as defined by common classification systems</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse cardiac events</measure>
    <time_frame>30 days</time_frame>
    <description>Occurrence of adverse cardiac events including all-cause mortality, target lesion and vessel revascularization (TLR and TVR).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse cardiac events</measure>
    <time_frame>12 months</time_frame>
    <description>Occurrence of adverse cardiac events including all-cause mortality, target lesion and vessel revascularization (TLR and TVR).</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">600</enrollment>
  <condition>Arterial Closure Device</condition>
  <condition>Percutaneous Coronary Intervention (PCI)</condition>
  <condition>Access Site Bleeding</condition>
  <condition>Adverse Cardiac Events</condition>
  <arm_group>
    <arm_group_label>Radial PCI with TR Band (TM)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with a PCI using the radial approach and the above radial compression device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femoral PCI with AngioSeal device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with a PCI using the femoral approach and the above femoral vascular closure device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femoral PCI with StarClose device</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TR Band (TM)</intervention_name>
    <arm_group_label>Radial PCI with TR Band (TM)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AngioSeal</intervention_name>
    <arm_group_label>Femoral PCI with AngioSeal device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>StarClose</intervention_name>
    <arm_group_label>Femoral PCI with StarClose device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent about the study

          -  Elective PCI with following indications:

        Stable coronary artery disease, proven myocardial ischemia; cardiac arrhythmia; syncope;
        Unstable AP defined as NSTEMI but without cardiac troponin elevation; NSTEMI; STEMI

          -  patient eligible for coronary angiography and both radial and femoral PCI

          -  requirement of using a vascular closure device (without contraindications)

        Exclusion Criteria:

          -  inability to understand and sign the informed consent term

          -  pregnancy

          -  less 18 years of age

          -  single diagnostic coronary angiography

          -  active or high bleeding risk (thrombocytopenia &lt;50,000/µl)

          -  femoral approach and PCI without using a vascular closure device

          -  other conditions hampering involvement in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>First Department of Medicine, University Medical Centre Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>May 14, 2015</study_first_submitted>
  <study_first_submitted_qc>May 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2015</study_first_posted>
  <last_update_submitted>October 30, 2019</last_update_submitted>
  <last_update_submitted_qc>October 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsmedizin Mannheim</investigator_affiliation>
    <investigator_full_name>Michael Behnes</investigator_full_name>
    <investigator_title>Sub-PI</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

